Temporal induction of Lhx8 by optogenetic control system for efficient bone regeneration.

Stem Cell Research & Therapy
Delan HuangChen Zhou

Abstract

The spatiotemporal regulation of essential genes is crucial for controlling the growth and differentiation of cells in a precise manner during regeneration. Recently, optogenetics was considered as a potent technology for sophisticated regulation of target genes, which might be a promising tool for regenerative medicine. In this study, we used an optogenetic control system to precisely regulate the expression of Lhx8 to promote efficient bone regeneration. Quantitative real-time PCR and western blotting were used to detect the expression of Lhx8 and osteogenic marker genes. Alkaline phosphatase staining and alizarin red staining were used to detect alkaline phosphatase activity and calcium nodules. A customized optogenetic expression system was constructed to regulate Lhx8, of which the expression was activated in blue light but not in dark. We also used a critical calvarial defect model for the analysis of bone regeneration in vivo. Moreover, micro-computed tomography (micro-CT), three-dimensional reconstruction, quantitative bone measurement, and histological and immunohistochemistry analysis were performed to investigate the formation of new bone in vivo. During the osteogenic differentiation of BMSCs, the expression levels ...Continue Reading

References

Oct 6, 1988·Nature·I SadowskiM Ptashne
Sep 10, 2005·Proceedings of the National Academy of Sciences of the United States of America·Daisuke Matsuoka, Satoru Tokutomi
Oct 19, 2006·Experimental Hematology·Donald P Lennon, Arnold I Caplan
Aug 27, 2009·The Journal of Physical Chemistry. B·Sadato KikuchiSeigo Yamauchi
Oct 6, 2009·Nature Biotechnology·Masayuki YazawaRicardo E Dolmetsch
Mar 23, 2010·Cell·Viviana GradinaruKarl Deisseroth
Oct 13, 2011·Biomedical Optics Express·Alexander Doronin, Igor Meglinski
Feb 5, 2013·Nature Methods·Lukasz J BugajDavid V Schaffer
Jul 8, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chen ZhouJunqi Ling
Jan 19, 2018·Nature Communications·Jessica E FrithJustin J Cooper-White
Mar 6, 2018·Current Opinion in Biotechnology·Heath E Johnson, Jared E Toettcher
Jul 4, 2018·Proceedings of the National Academy of Sciences of the United States of America·Jiawei ShaoHaifeng Ye
Sep 21, 2018·Advances in Experimental Medicine and Biology·Yu Wei, Yao Sun
Sep 28, 2018·Biomaterials·Diana LopesJoão F Mano
Mar 16, 2019·Nature Communications·Michael H BerryEhud Y Isacoff
Jul 31, 2019·Cells·Xiaorong FuAnd Guanbin Song
Oct 16, 2019·Nature Methods·Claire N BedbrookFrances H Arnold
Dec 27, 2019·World Journal of Stem Cells·Yu-Hao ChengQin Bian
Jun 18, 2020·Biochemical and Biophysical Research Communications·Ji-Youn Kim, Pill-Hoon Choung
Aug 8, 2020·Frontiers in Neural Circuits·Yi ShenMarie-Eve Paquet
Dec 29, 2020·Journal of Dental Research·A NagasakiM J Somerman

❮ Previous
Next ❯

Software Mentioned

Avizo
- Toolbox
IHC
GraphPad Prism
ImageJ

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.